Antigen sensitivity and T-cell receptor avidity as critical determinants of HIV control

Current Opinion in HIV and AIDS

Volumn 6, Issue 3, 2011, Pages 157-162

  Appay, Victor ^a   Iglesias, Maria C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

avidity; efficacy; T cell receptor; T cells; virus

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT VACCINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE CLONE; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; VACCINATION; VIRUS LOAD; VIRUS REPLICATION;

AIDS VACCINES; ANTIGENS, VIRAL; HIV; HIV INFECTIONS; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 79955470991     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283453dfd     Document Type: Article

References (52)

1. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-11991. (Pubitemid 33115870)
2. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714. (Pubitemid 30159236)
3. Sauce D, Almeida JR, Larsen M, et al. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 2007; 21:2005-2013. (Pubitemid 47462149)
4. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53. (Pubitemid 46067385)
5. Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med 2008; 14:623-628. (Pubitemid 351809548)
6. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781-4789. (Pubitemid 43882629)
7. Almeida JR, Price DA, Papagno L, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 2007; 204:2473-2485. (Pubitemid 47529331)
8. Hersperger AR, Pereyra F, Nason M, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010; 6:e1000917.
9. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-1068. (Pubitemid 35363659)
10. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A 2007; 104: 6776-6781. (Pubitemid 47175577)
11. Migueles SA, Osborne CM, Royce C, et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008; 29:1009-1021.
12. Speiser DE, Romero P. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity. Semin Immunol 2010; 22:144-154.
13. Sacha JB, Chung C, Rakasz EG, et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J Immunol 2007; 178:2746-2754. (Pubitemid 46333151)
14. Sacha JB, Chung C, Reed J, et al. Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation. J Virol 2007; 81:11703-11712. (Pubitemid 47623802)
15. Bihl F, Frahm N, Di Giammarino L, et al. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J Immunol 2006; 176:4094-4101. (Pubitemid 44264388)
16. Almeida JR, Sauce D, Price DA, et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 2009; 113:6351-6360.
17. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13:843-850. (Pubitemid 47038186)
18. Precopio ML, Betts MR, Parrino J, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. J Exp Med 2007; 204:1405-1416. (Pubitemid 46919878)
19. Bennett MS, Joseph A, Ng HL, et al. Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes. AIDS 2010; 24:2619-2628.
20. Lichterfeld M, Yu XG, Mui SK, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol 2007; 81:4199-4214. (Pubitemid 46586914)
21. Leligdowicz A, Onyango C, Yindom LM, et al. Highly avid, oligoclonal, earlydifferentiated antigen-specific CD8+ T cells in chronic HIV-2 infection. Eur J Immunol 2010; 40:1963-1972.
22. Belyakov IM, Kuznetsov VA, Kelsall B, et al. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006; 107:3258-3264.
23. Vingert B, Perez-Patrigeon S, Jeannin P, et al. HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity. PLoS Pathog 2010; 6:e1000780.
24. O'Connor DH, Allen TM, Vogel TU, et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002; 8:493-499. (Pubitemid 34546752)
25. Yang OO, Sarkis PT, Trocha A, et al. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J Immunol 2003; 171:3718-3724. (Pubitemid 37254577)
26. Chen H, Piechocka-Trocha A, Miura T, et al. Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes. J Virol 2009; 83:3138-3149.
27. Payne RP, Kloverpris H, Sacha JB, et al. Efficacious early antiviral activity of HIV Gag-and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol 2010; 84:10543-10557.
28. Draenert R, Verrill CL, Tang Y, et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol 2004; 78:630-641. (Pubitemid 38067584)
29. Harari A, Cellerai C, Enders FB, et al. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci U S A 2007; 104:16233-16238. (Pubitemid 350099390)
30. Stone JD, Chervin AS, Kranz DM. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 2009; 126:165-176.
31. Price DA, Asher TE, Wilson NA, et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med 2009; 206:923-936.
32. Varela-Rohena A, Molloy PE, Dunn SM, et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008; 14:1390-1395.
33. Tenzer S, Wee E, Burgevin A, et al. Antigen processing influences HIVspecific cytotoxic T lymphocyte immunodominance. Nat Immunol 2009; 10:636-646.
34. Casartelli N, Guivel-Benhassine F, Bouziat R, et al. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J Exp Med 2010; 207:39-49.
35. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354. (Pubitemid 44435155)
36. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-1202. (Pubitemid 44527357)
37. Jones RB, Ndhlovu LC, Barbour JD, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205:2763-2779.
38. Streeck H, Brumme ZL, Anastario M, et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med 2008; 5:e100.
39. Daucher M, Price DA, Brenchley JM, et al. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. J Virol 2008; 82:4102-4114. (Pubitemid 351521245)
40. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of highor low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A 1996; 93:4102-4107. (Pubitemid 26144250)
41. Bullock TN, Mullins DW, Engelhard VH. Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol 2003; 170:1822-1829. (Pubitemid 36197398)
42. Hangalapura BN, Oosterhoff D, Aggarwal S, et al. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus. J Immunother 2010; 33:706-715.
43. Kroger CJ, Amoah S, Alexander-Miller MA. Cutting edge: dendritic cells prime a high avidity CTL response independent of the level of presented antigen. J Immunol 2008; 180:5784-5788.
44. Pudney VA, Metheringham RL, Gunn B, et al. DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity antitumor CD8+ T cells. Eur J Immunol 2010; 40:899-910.
45. Oh S, Hodge JW, Ahlers JD, et al. Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol 2003; 170:2523-2530. (Pubitemid 36245642)
46. Yang S, Hodge JW, Grosenbach DW, Schlom J. Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol 2005; 175: 3715-3723. (Pubitemid 41292031)
47. Markiewicz MA, Wise EL, Buchwald ZS, et al. IL-12 enhances CTL synapse formation and induces self-reactivity. J Immunol 2009; 182:1351-1361.
48. Oh S, Perera LP, Burke DS, et al. IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci U S A 2004; 101:15154-15159. (Pubitemid 39391734)
49. Apte SH, Baz A, Groves P, et al. Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells. Proc Natl Acad Sci U S A 2008; 105:17475-17480.
50. Wooldridge L, Laugel B, Ekeruche J, et al. CD8 controls T cell cross-reactivity. J Immunol 2010; 185:4625-4632.
51. Malherbe L, Mark L, Fazilleau N, et al. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 2008; 28:698-709.
52. Zhu Q, Egelston C, Gagnon S, et al. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 2010; 120:607-616.